The induction of tumor-specific CD4+ T cells via major histocompatibility complex class II is required to gain optimal anti-tumor immunity against B16 melanoma cell line in tumor immunotherapy using dendritic cells
Yasuhiro Fujisawa, Tsukasa Nabekura, Tomohei Nakao, Yasuhiro Nakamura, Takenori Takahashi, Yasuhiro Kawachi, Fujio Otsuka, Masafumi OnoderaVolume:
18
Year:
2009
Language:
english
Pages:
8
DOI:
10.1111/j.1600-0625.2008.00802.x
File:
PDF, 624 KB
english, 2009